Regulation

Is Tesamorelin legal in Europe? It was never authorised by the EMA — an application was withdrawn in 2012 — so in the EU it is a research reagent only. An honest, source-cited look at what ‘legal’ really means, including its WADA status.

Is Epitalon legal in Europe? It has no EMA authorisation and is not approved anywhere in the world as a marketed medicine, so in the EU it is a research reagent only. An honest, source-cited look at what ‘legal’ really means here.

Is NMN legal in Europe? It is classified as a Novel Food — and as of 2026 still unauthorised, with EFSA opinions in and applications pending. The honest, source-cited answer for researchers.

The 2026 list names dozens of growth-hormone peptides as prohibited at all times for athletes. But the silences in Section S2 — BPC-157, TB-500, MOTS-c — matter as much as the named substances.

RUO is a labelling category about intended use, not a quality grade or a safety claim. It is legitimate for genuine laboratory science — and routinely abused by the grey market as a fig leaf. Here is what the label actually does, and what it cannot.

A research peptide sold across Europe, never approved as a medicine, and quietly governed by the question almost nobody asks correctly.

A neutral 2026 map of how the FDA, the EMA and the anti-doping world actually treat research peptides — and why “Research Use Only” is a defined legal frame, not a loophole.

On 1 June 2026 the European Medicines Agency published its first rulebook for manufacturing synthetic-peptide medicines. Here is what it actually says, what it does not touch, and why it quietly raises the quality bar for everyone.

A US advisory committee meets on 23–24 July 2026 to weigh whether a group of research peptides — including BPC-157 and TB-500 — should return to a category permitting regulated compounding. Here is what is actually being decided, and what it does not change.